Showing 2591-2600 of 4067 results for "".
- AI-Generated ‘Future X-rays’ Offer New Way to Forecast Osteoarthritis Progressionhttps://reachmd.com/news/ai-generated-future-x-rays-offer-new-way-to-forecast-osteoarthritis-progression/2483969/A new AI-powered system may soon give patients with knee osteoarthritis a glimpse into their orthopedic future—quite literally. In a study presented at the MICCAI 2025 conference, researchers from the University
- Genetic Score in ZMIZ1/TGF‑β/STAT Pathway Forecasts Biologic Drug Persistence in Psoriasishttps://reachmd.com/news/genetic-score-in-zmiz1tgfstat-pathway-forecasts-biologic-drug-persistence-in-psoriasis/2483888/In a newly published study in Advances in Therapy, investigators report that a pathway‑based genetic score may predict how long patients with moderate
- Unlocking Liver Regeneration: Single-Cell Transcriptomics at the Forefronthttps://reachmd.com/news/unlocking-liver-regeneration-single-cell-transcriptomics-at-the-forefront/2483226/Clinicians treating acute liver failure are racing against hours to days of deterioration while donor organs remain scarce; against this backdrop, high-resolution single-cell datasets</
- Balancing Force and Performance: Insights into Kinematics and Conditioninghttps://reachmd.com/news/balancing-force-and-performance-insights-into-kinematics-and-conditioning/2483159/Integrating biomechanics and neuromuscular conditioning remains a core clinical challenge in sports medicine. Recent advancements highlight the significance of these fields in optimizing athletic performance and preventing injuries. The dynamic interplay between biom
- Amarte Relaunches Dermatologist-Formulated Ultra Veil Daily SPF 40https://reachmd.com/news/amarte-relaunches-dermatologist-formulated-ultra-veil-daily-spf-40/2483103/Amarte Skin Care has relaunched its flagship sunscreen, ULTRA VEIL® DAILY SPF 40, according to a press release from the manufacturer. The updated product maintains its position as a top-tier hybrid sunscreen, the press release
- Innovations in Breast Cancer Surgery: Precision Medicine at the Forefronthttps://reachmd.com/news/innovations-in-breast-cancer-surgery-precision-medicine-at-the-forefront/2483041/Breast cancer treatment is undergoing a transformative evolution, as advanced surgical methods and genetic testing bring us closer to realizing the full potential of precision medicine, in line with contemporary NCCN and ASCO guidance. These advancements are continually reshaping pa
- Biosimilar STEQEYMA Now Approved for All Ustekinumab Dosage Forms, Strengthshttps://reachmd.com/news/Biosimilar-STEQEYMA-Now-Approved-All-Ustekinumab-Dosage-Forms-Strengths/2475172/The US Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, according to a press release from Celltrion, Inc. The additional pre
- AI-Driven Models Enhance Dialysis by Forecasting and Customizing Treatmentshttps://reachmd.com/news/ai-driven-models-enhance-dialysis-by-forecasting-and-customizing-treatments/2475112/Unpredictable fluid removal rates and solute clearance, compounded by individual patient variability, continue to challenge clinicians in delivering optimal dialysis. RRI’s
- Gene Therapy Moves Forward in Diabetic Macular Edema Managementhttps://reachmd.com/news/gene-therapy-moves-forward-in-diabetic-macular-edema-management/2474921/Gene therapy is influencing the management of diabetic macular edema, with the recent FDA granting RMAT
- Analysis Forecasts 140% Rise in Basal Cell Carcinoma by 2050https://reachmd.com/news/analysis-forecasts-140-rise-in-basal-cell-carcinoma-by-2050/2474797/The global burden of skin cancer among adults aged 65 and older has increased steadily over the past three decades and is expected to continue rising through 2050, according to a new analysis of Global Burden of Disease (GBD) Study data.